Replica Analytics, an Ottawa, ON, Canada-based provider of privacy protective synthetic data, raised over $1m in new pre-seed funding.
The funding came from three sources:
- FACIT, a commercialization venture firm supporting oncology innovations;
- MITACS, a national, not-for-profit organization supporting innovation within Canadian industry in collaboration with universities; and
- an international angel investor group.
The company intends to use the funds to accelerate research to develop its novel data synthesis and data simulation technologies.
Led by Khaled El Emam, Co-founder and Director, Replica Analytics is a global software company that has invented a technology to generate privacy-protected synthetic data, while maintaining the statistical properties of real data, and without breaching regulatory privacy requirements. Its latest product, Replica Synthesis, provides synthetic real-world data and synthetic clinical trial data to data scientists and researchers.